Uploaded February 2025 | Updated September 2026, 2 hours ago
Next week, AstraZeneca, Disney, and Palantir are set to report, offering key insights for investors. Can AstraZeneca navigate pipeline progress and fraud investigations? Is Disney turning the corner on its streaming and parks strategy? And can Palantir deliver growth to justify its sky-high valuation? Watch for a quick overview of the week ahead! Don’t forget to subscribe for more market insights.
Next week, AstraZeneca, Disney, and Palantir are set to report, offering key insights for investors. Can AstraZeneca navigate pipeline progress and fraud investigations? Is Disney turning the corner on its streaming and parks strategy? And can Palantir deliver growth to justify its sky-high valuation? Watch for a quick overview of the week ahead! Don’t forget to subscribe for more market insights.










